Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination

Vaccine

Volumn 29, Issue 44, 2011, Pages 7835-7841

  Zhu, Chang Lin ^a   Liu, Ping ^a   Chen, Taoyang ^b,c   Ni, Zhengping ^b   Lu, Ling Ling ^b   Huang, Fei ^b   Lu, Jianhua ^b   Sun, Zongtang ^a   Qu, Chunfeng ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b QIDONG LIVER CANCER INSTITUTE   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Booster; Cellular immunity; Hepatitis B; Immune memory; Neonatal hepatitis B vaccination

Indexed keywords

EPITOPE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VECON; VIRUS DNA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN EXPERIMENT; IMMUNOLOGICAL MEMORY; MALE; MUTATION; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION;

ADULT; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFANT, NEWBORN; MALE; VACCINATION; YOUNG ADULT;

EID: 80053613634     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.098     Document Type: Article

References (24)

1. CDC Progress in hepatitis B prevention through universal infant vaccination-China, 1997-2006. Morb Mortal Wkly Rep 2007, 56(May (18)):441-445.
2. Sun Z., Ming L., Zhu X., Lu J. Prevention and control of hepatitis B in China. J Med Virol 2002, 67(July (3)):447-450.
3. Chen D.S. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol 2009, 50(April (4)):805-816.
4. Zhou Y.H., Wu C., Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2009, 122(January (1)):98-102.
5. Chen J.G., Zhu J., Parkin D.M., Zhang Y.H., Lu J.H., Zhu Y.R., et al. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer 2006, 119(September (6)):1447-1454.
6. Yuen M.F., Lim W.L., Chan A.O., Wong D.K., Sum S.S., Lai C.L. 18-Year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clin Gastroenterol Hepatol 2004, 2(October (10)):941-945.
7. Zanetti A.R., Mariano A., Romano L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005, 366(October (9494)):1379-1384.
8. John T.J., Cooksley G. Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations?. J Gastroenterol Hepatol 2005, 20(January (1)):5-10.
9. Lu C.Y., Ni Y.H., Chiang B.L., Chen P.J., Chang M.H., Chang L.Y., et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008, 197(May (10)):1419-1426.
10. Jan C.F., Huang K.C., Chien Y.C., Greydanus D.E., Davies H.D., Chiu T.Y., et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 2010, 51(May (5)):1547-1554.
11. Hu Y., Wu Q., Xu B., Zhou Z., Wang Z., Zhou Y.H. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants. Vaccine 2008, 26(November (48)):6064-6067.
12. Wang R.X., Boland G., Guo Y., Lei S.P., Yang C.H., Chen J., et al. Is a low dose of hepatitis B vaccine enough for a rapid vaccination scheme?. World J Gastroenterol 2003, 9(10):2353-2355.
13. Xu L., Wei Y., Chen T., Lu J., Zhu C.L., Ni Z., et al. Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination. Vaccine 2010, 28(August (37)):5986-5992.
14. Sun Z., Zhu Y., Stjernsward J., Hilleman M., Collins R., Zhen Y., et al. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study. Cancer Detect Prev 1991, 15:313-318.
15. Sun Z., Lu J., Lu P., Ming L. Immunological approaches to prevent chronic hepatitis and hepatocellular carcinoma. Gastrolenterol Hepatol 2000, 15(Suppl. I):68.
16. West D.J., Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996, 14(August (11)):1019-1027.
17. Chinchai T., Chirathaworn C., Praianantathavorn K., Theamboonlers A., Hutagalung Y., Bock P.H., et al. Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunol 2009, 22(April (2)):125-130.
18. Bauer T., Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006, 24(January (5)):572-577.
19. Yang P.L., Althage A., Chung J., Maier H., Wieland S., Isogawa M., et al. Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A 2010, 107(January (2)):798-802.
20. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995, 13:29-60.
21. Edmunds W.J., Medley G.F., Nokes D.J., Hall A.J., Whittle H.C. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 1993, 253(August (1337)):197-201.
22. Brechot C., Degos F., Lugassy C., Thiers V., Zafrani S., Franco D., et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985, 312(January (5)):270-276.
23. Hsia C.C., Scudamore C.H., Di Bisceglie A.M., Tabor E. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America. J Med Virol 2003, 70(May (1)):20-26.
24. Candotti D., Allain J.P. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009, 51(October (4)):798-809.